Interstitial Lung Disease
📧 Sign up to get email alerts when something new happens for Interstitial Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD [NA]
The clinical trial assessing continuous positive airway pressure therapy in patients with obstructive sleep apnea and interstitial lung dise…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Investigation of H01 in Adults With Pulmonary Hypertension Including Interstitial Lung Disease (The SATURN Study). [Phase 2]
Phase 2 trial evaluating H01 in adults with pulmonary hypertension including interstitial lung disease. The study has completed and results …
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease
Completed results from Boehringer Ingelheim's trial evaluate the use of oxygen therapy in patients with fibrotic interstitial lung disease; …
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases [Phase 2, Phase 3]
This clinical trial update notes a Phase 2/3 study evaluating olokizumab for progressive fibrosing interstitial lung diseases, and the trial…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Integrating ePReBMs From Phoenix in Respiratory Diseases [NA]
A clinical trial evaluating ePReBMs from Phoenix in respiratory diseases has been terminated, with conditions including pulmonary hypertensi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Assessment of Interstitial Lung Disease in Rheumatoid Arthritis by Lung Ultrasound
This clinical trial update reports on evaluating interstitial lung disease in rheumatoid arthritis using lung ultrasound.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment
Boehringer Ingelheim conducted a study on progression to progressive fibrosing interstitial lung disease (PF-ILD) and how it is managed and …
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy)
This clinical trial update reports the completion of a study using laser-induced breakdown spectroscopy to image elemental composition in lu…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Advancing Symptom Alleviation With Palliative Treatment [NA]
A completed clinical trial is reported evaluating palliative treatment for symptom relief in patients with heart failure and chronic lung di…
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease [Phase 4]
A Phase 4 trial comparing tofacitinib versus methotrexate in patients with rheumatoid arthritis and interstitial lung disease has been termi…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease.
Clinical trial update showing completion of a study on anti-neutrophil cytoplasmic antibody in interstitial lung disease and ANCA-associated…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Reducing Disparities in the Quality of Advance Care Planning for Older Adults [NA]
A Duke University-sponsored trial examining disparities in the quality of advance care planning for older adults has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Nebulized Fentanyl in Patients With Mild to Moderate Interstitial Lung Disease and Chronic Dyspnea [Phase 3]
A Phase 3 trial evaluating nebulized fentanyl for dyspnea in patients with mild to moderate interstitial lung disease has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Families-At-risk for Interstitial Lung Disease Study
Completed clinical study investigating families at risk for interstitial lung disease and idiopathic pulmonary fibrosis; results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: Rituxmab Versus IL-6 in Treating ILD [Phase 2, Phase 3]
Phase 2/3 trial comparing Rituxmab to IL-6 in treating Interstitial Lung Disease and scleroderma has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung Diseases [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating autologous lung stem cell transplantation for interstitial lung diseases.
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease [Phase 4]
A Phase 4 trial update evaluating systemic corticosteroids for treatment of post-COVID-19 interstitial lung disease has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease [NA]
Clinical trial update on aerobic exercise therapy for patients with interstitial lung disease, including idiopathic pulmonary fibrosis, comp…
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease. [Phase 2]
Phase 2 clinical trial update investigating tofacitinib for rheumatoid arthritis-related interstitial lung disease (RA-ILD).
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD) [Phase 3]
A Phase 3 pediatric study evaluating absorption and tolerability of nintedanib in children with interstitial lung disease; results have been…
-
CLINICAL_TRIALS trial_result · 2023-01-09Clinical Trial Update: Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity Pneumonitis [Phase 2]
Phase 2 study of pirfenidone in fibrotic hypersensitivity pneumonitis was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE [Phase 2, Phase 3]
Open-label extension study assessing inhaled treprostinil in adults with pulmonary hypertension associated with interstitial lung disease, i…
-
CLINICAL_TRIALS trial_result · 2022-05-26Clinical Trial Update: Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis [Phase 4]
A Phase 4 trial evaluating efficacy and safety of triple therapy in anti-MDA5 antibody-positive dermatomyositis with interstitial lung disea…
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Clinical Study of MMF in Treatment of IIM-ILD and Its Effect on Peripheral Blood Treg Cells [Phase 4]
A Phase 4 clinical trial evaluating mycophenolate mofetil (MMF) in treating idiopathic inflammatory myopathy-associated interstitial lung di…
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD [Phase 2, Phase 3]
A Phase 2/Phase 3 trial comparing rituximab to cyclophosphamide in connective tissue disease–associated interstitial lung disease has comple…